If generative AI could contribute in the slightest to such discoveries—as has been promised since the start of the AI ...

In recent years, cell therapies have developed alongside chemotherapy and immunotherapy to become a new pillar in the ...

Penpulimab has picked up a pair of approvals in nasopharyngeal carcinoma (NPC), becoming only the second drug to be cleared ...

Peter Loftus is a reporter for The Wall Street Journal in Philadelphia covering the pharmaceutical and medical-device ...

A novel combination therapy offers better outcomes for patients with KRAS G12C metastatic colorectal cancer that have stopped ...